Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1
- 1 September 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (9), 1277-1282
- https://doi.org/10.1161/atvbaha.109.188995
Abstract
Objective— Patients with chronic kidney disease (CKD) have the highest risk for atherosclerotic cardiovascular disease (CVD). Current interventions have been insufficiently effective in lessening excess incidence and mortality from CVD in CKD patients versus other high-risk groups. The mechanisms underlying the heightened risk remain obscure but may relate to differences in CKD-induced atherogenesis, including perturbation of macrophage cholesterol trafficking. Methods and Results— We examined the impact of renal dysfunction on macrophage cholesterol homeostasis in the apoE −/− mouse model of atherosclerosis. Renal impairment induced by uninephrectomy dramatically increased macrophage cholesterol content, linked to striking impairment of macrophage cholesterol efflux. This blunted efflux was associated with downregulation of the cholesterol transporter ATP-binding cassette transporter A1 (ABCA1) and activation of the nuclear factor-kappa B (NF-κB). Treatment with the angiotensin receptor blocker (ARB) losartan decreased NF-κB and restored cholesterol efflux. Conclusions— Our findings show that mild renal dysfunction perturbs macrophage lipid homeostasis by inhibiting cholesterol efflux, mediated by decreased ABCA1 transporter and activation of NF-κB, and that ARB can restore cholesterol efflux.Keywords
This publication has 48 references indexed in Scilit:
- LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Achievement of Therapeutic Goals and Utilization of Evidence-Based Cardiovascular Therapies in Coronary Heart Disease Patients With Chronic Kidney DiseaseThe American Journal of Cardiology, 2008
- Nuclear factor-κB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injuryCurrent Opinion in Nephrology and Hypertension, 2008
- High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1Proceedings of the National Academy of Sciences of the United States of America, 2007
- Angiotensin II increases the cholesterol content of foam cells via down-regulating the expression of ATP-binding cassette transporter A1Biochemical and Biophysical Research Communications, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004
- Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiencyKidney International, 2004
- Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE StudyKidney International, 2004
- Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW CellsInfection and Immunity, 2002
- Angiotensin II Reduces Macrophage Cholesterol Efflux: A Role for the AT-1 Receptor but Not for the ABC1 TransporterBiochemical and Biophysical Research Communications, 2002